These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8825138)

  • 1. Determination of ErbB2 protein in breast cancer tissues by different methods. Relationships with other biological parameters.
    Piffanelli A; Dittadi R; Catozzi L; Gion M; Capitanio G; Gelli MC; Brazzale A; Malagutti R; Pelizzola D; Menegon A; Giovannini G; Gardini G
    Breast Cancer Res Treat; 1996; 37(3):267-76. PubMed ID: 8825138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunometric assays of ras and c-erbB-2/neu overexpression in breast cancer: a pilot study.
    Pelizzola D; Malagutti R; Giovannini G; Indelli M; Carcoforo P; Piffanelli A
    Int J Biol Markers; 1999; 14(3):178-85. PubMed ID: 10569141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of HER-2/neu oncoprotein in human breast cancer: a comparison of immunohistochemical and western blot techniques.
    Molina R; Ciocca DR; Tandon AK; Allred DC; Clark GM; Chamness GC; Gullick WJ; McGuire WL
    Anticancer Res; 1992; 12(6B):1965-71. PubMed ID: 1363511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High sensitivity and specificity of immunohistochemistry for the detection of hormone receptors in breast carcinoma: comparison with biochemical determination in a prospective study of 793 cases.
    Zafrani B; Aubriot MH; Mouret E; De Crémoux P; De Rycke Y; Nicolas A; Boudou E; Vincent-Salomon A; Magdelénat H; Sastre-Garau X
    Histopathology; 2000 Dec; 37(6):536-45. PubMed ID: 11122436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous quantitative analyses of c-erbB-2 protein, epidermal growth factor receptor, cathepsin D, and hormone receptors in breast cancer.
    Iwase H; Itoh Y; Kuzushima T; Yamashita H; Iwata H; Toyama T; Hara Y; Kobayashi S
    Cancer Detect Prev; 1997; 21(1):29-35. PubMed ID: 9043760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ErbB2 assay in breast cancer: possibly improved clinical information using a quantitative method.
    Dittadi R; Brazzale A; Pappagallo G; Salbe C; Nascimben O; Rosabian A; Gion M
    Anticancer Res; 1997; 17(2B):1245-7. PubMed ID: 9137481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of steroid receptors in breast cancer: relationship between EIA and IHC methods.
    Lerma E; Esqué C; Peiró G; Mora J; Cerdá I; Prat J
    Scand J Clin Lab Invest; 1994 Dec; 54(8):591-4. PubMed ID: 7709160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoenzymatic assay of erbB2 protein in cancer and non-malignant breast tissue. Relationships with clinical and biochemical parameters.
    Dittadi R; Donisi PM; Brazzale A; Marconato R; Spina M; Gion M
    Anticancer Res; 1992; 12(6B):2005-10. PubMed ID: 1363513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between western blotting, immunohistochemical and ELISA assay for p185neu quantitation in breast cancer specimens.
    Dittadi R; Catozzi L; Gion M; Brazzale A; Capitanio G; Gelli MC; Menegon A; Gardini G; Malagutti R; Piffanelli A
    Anticancer Res; 1993; 13(5C):1821-4. PubMed ID: 7903522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid receptor measurement in breast cancers: comparison between ligand binding and enzyme-immunoassay in cytosolic and nuclear extracts.
    Luqmani YA; Temmim L; Memon A; Ali MA; Parkar AH
    Int J Cancer; 1997 May; 71(4):526-38. PubMed ID: 9178804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of p185(HER-2/neu) protein in breast cancer and its association with other prognostic factors.
    Valerón PF; Chirino R; Vega V; Falcón O; Rivero JF; Torres S; León L; Fernández L; Pestano J; Díaz-Chico B; Díaz-Chico JC
    Int J Cancer; 1997 Apr; 74(2):175-9. PubMed ID: 9133451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer.
    Konecny G; Pauletti G; Pegram M; Untch M; Dandekar S; Aguilar Z; Wilson C; Rong HM; Bauerfeind I; Felber M; Wang HJ; Beryt M; Seshadri R; Hepp H; Slamon DJ
    J Natl Cancer Inst; 2003 Jan; 95(2):142-53. PubMed ID: 12529347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous immunohistochemical and biochemical hormone receptor assessment in breast cancer provides complementary prognostic information.
    Biesterfeld S; Schröder W; Steinhagen G; Koch R; Veuskens U; Schmitz FJ; Handt S; Böcking A
    Anticancer Res; 1997; 17(6D):4723-9. PubMed ID: 9494596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of ERBB2 protein expression in breast cancer: three levels of expression defined by their clinico-pathological correlations.
    Cuny M; Simony-Lafontaine J; Rouanet P; Grenier J; Valles H; Lavaill R; Louason G; Causse A; Lequeux N; Thierry C
    Oncol Res; 1994; 6(4-5):169-76. PubMed ID: 7841539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of c-erbB-2 protein in primary breast cancer tissue extract using an enzyme immunoassay.
    Watanabe T; Fukutomi T; Tsuda H; Adachi I; Nanasawa T; Yamamoto H; Abe K
    Jpn J Cancer Res; 1993 Dec; 84(12):1279-86. PubMed ID: 7904987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of cytosol c-erbB-2 protein in breast cancer by sandwich enzyme immunoassay.
    Imoto S; Ohkura H; Sugano K; Sasaki Y; Ito K; Igarashi T; Ohtsu T; Fujii H; Minami H; Hasebe T; Mukai K
    Jpn J Clin Oncol; 1998 Feb; 28(2):92-6. PubMed ID: 9544822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of oestrogen and progesterone receptors, and c-erbB-2 in carcinoma of the breast in Trinidadian women.
    Rao AV; Mohammed WA; Ragoonanan C; Omo-Igbinomwanhia NE
    West Indian Med J; 2002 Mar; 51(1):4-9. PubMed ID: 12089875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols.
    Foekens JA; Portengen H; van Putten WL; Peters HA; Krijnen HL; Alexieva-Figusch J; Klijn JG
    Cancer Res; 1989 Nov; 49(21):5823-8. PubMed ID: 2676151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of host and histopathological factors on the discrepancies in estrogen receptor, and progesterone receptor, and HER2 status between core needle biopsy and surgically excised tumors.
    Nakamura R; Yamamoto N; Shiina N; Miyaki T; Ikebe D; Itami M; Shida T; Miyazaki M
    Breast; 2016 Apr; 26():141-7. PubMed ID: 26732051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical value of enzyme immunoassay of epidermal growth factor receptor in human breast cancer.
    Iwase H; Kobayashi S; Itoh Y; Kuzushima T; Yamashita H; Iwata H; Naito A; Yamashita T; Itoh K; Masaoka A
    Breast Cancer Res Treat; 1993 Dec; 28(3):215-21. PubMed ID: 7912560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.